Despite differences in study cohorts, previous studies have reported the prognostic value of biomarkers such as BCL2, tumor-infiltrating lymphocytes, specific microRNAs, and circulating tumor cells [32,33,34,35]. Here, BCL2 is linked to neoplasm.